Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | TAC-001 |
Trade Name | |
Synonyms | TRAAC TAC-001|TAC 001|TAC001 |
Drug Descriptions |
TAC-001 comprises T-CpG, a TLR9 agonist, linked to an anti-CD22 antibody, which potentially results in enhanced antitumor immune response (Cancer Res 2021;81(13_Suppl):Abstract nr 1721). |
DrugClasses | TLR9 Agonist 9 |
CAS Registry Number | NA |
NCIT ID | C190597 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TAC-001 | TAC-001 | 0 | 1 |